Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Smoking may worsen hair loss, but more research is needed.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Low vitamin D levels are linked to hair loss, and vitamin D might help treat it.

Aldactone effectively reduces hair thickness in women with excessive hair growth, both alone and with other treatments.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Topical treatments for hair loss can be effective but need careful safety evaluation.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Androgens and other hormones affect hair growth and skin conditions like acne.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Women with androgenetic alopecia have lower zinc and iron levels.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

New 5% minoxidil solution improves scalp hydration, reduces redness, and may be safer for sensitive users.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

The document concludes that effectively managing PCOS requires a multifaceted approach.